Professor shares amazing tip to deal with hay fever spike that hits between 5-7pm everyday
HAY FEVER season is starting to kick in, with many people complaining of sneezing and other irritating symptoms. If your symptoms tend to worsen in the evening, Allergy expert Professor Adam Fox has a handy tip. (Source: Daily Express - Health)
Source: Daily Express - Health - March 24, 2021 Category: Consumer Health News Source Type: news

Prenatal, Postnatal Exposure to PM2.5 Linked to Pediatric Allergic Rhinitis
FRIDAY, March 19, 2021 -- Prenatal and postnatal exposure to fine particulate matter (PM2.5) is associated with the development of allergic rhinitis in children, according to a study published online March 11 in Thorax. Yu-Ting Lin, M.D., Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 19, 2021 Category: Pharmaceuticals Source Type: news

Combining public health and environmental science to develop pollen forecasting
(Bangor University) New research, combining healthcare data with ground-breaking ecological techniques, could set a roadmap for refining future pollen forecasts.Current pollen forecasts, crucial for people with allergic asthma or hay fever to manage their symptoms, rely on measuring the total load of grass pollen in the atmosphere. However, these do not distinguish between pollen from different types of grass.Now, a potential link between pollen from certain grass species and respiratory health issues has been revealed. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 11, 2021 Category: Biology Source Type: news

Covid new strain symptoms: How to tell if it's Covid or hay fever according to an expert
NEW strains of the Covid virus have been found in the UK - the Kent, South African and Brazil variants are circulating. But with hay fever now in the mix, and with similar symptoms, how can you tell if it's hay fever or Covid you have? Dr Belina Griffiths reveals how you can tell which one you're suffering from. (Source: Daily Express - Health)
Source: Daily Express - Health - March 6, 2021 Category: Consumer Health News Source Type: news

Coronavirus update: Hay fever nasal spray can offer protection - This Morning's Dr Chris
CORONAVIRUS enters the body through the airways so nasal sprays can provide a barrier to entry. Speaking to Holly and Phil on ITV's This Morning, Dr Chris explains how a hay fever nasal spray can double up as protection against COVID-19. (Source: Daily Express - Health)
Source: Daily Express - Health - February 23, 2021 Category: Consumer Health News Source Type: news

Nasal spray made from CHILLIES could be the answer to a persistent blocked nose, research suggests 
The spray is designed for people whose nasal stuffiness is not caused by allergies such as hay fever, but rather by non-allergic rhinitis, a condition that affects up to six million people in the UK. (Source: the Mail online | Health)
Source: the Mail online | Health - February 22, 2021 Category: Consumer Health News Source Type: news

Glenmark arm gets Russian health ministry nod for nasal spray Ryaltris
In Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 18-38 per cent. Allergic rhinitis can impact a person's quality of life and lead to functional impairments, as well as increase the risk of having asthma, the company said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2021 Category: Pharmaceuticals Source Type: news

Hay fever warning: 'Pollen bomb on the way' - Dr Sara offers best tips to prevent symptoms
HAY FEVER sufferers have been warned warming temperatures over the coming days could spark a ‘pollen bomb'. With tree pollen set to hit sufferers first, what can you do to prevent symptoms? Dr Sara Kayat offered her advice on This Morning. (Source: Daily Express - Health)
Source: Daily Express - Health - February 17, 2021 Category: Consumer Health News Source Type: news

Pollen season grows 20 days in 30 years as climate crisis hits hay fever sufferers
Pollen released by plants is also more intense than in 1990 in bad news for those with allergies, research in US and Canada findsThe climate crisis is multiplying the miseries faced by people with allergies, with new research finding that the pollen season in North America is now an average 20 days longer than it was three decades ago.Related:How urban planners' preference for male trees has made your hay fever worseContinue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 8, 2021 Category: Science Authors: Oliver Milman Tags: Environment Allergies Climate change Plants Science Source Type: news

DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) Becomes the First FDA-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
January 15, 2021 (HORSHAM, Pa.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis.[1] DARZALEX FASPRO® is the first and only FDA-approved treatment for patients with this blood cell disorder that is associated with the production of an abnormal protein, which leads to the deterior...
Source: Johnson and Johnson - January 16, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Does moisturising baby skin prevent eczema or food allergies?
Skin care treatments in babies, such as using moisturisers on the skin during the first year of life, probably do not stop them from developing eczema, and probably increase the chance of skin infection.The authors are uncertain how skin care treatments might affect the chances of developing a food allergy. We need evidence from well-conducted studies to determine effects of skin care on food allergies in babies.What are allergies?An immune response is how the body recognises and defends itself against substances that appear harmful. An allergy is a reaction of the body ' s immune system to a particular food or substance (...
Source: Cochrane News and Events - January 14, 2021 Category: Information Technology Authors: Katie Abbotts Source Type: news

Coronavirus Disease 2019 and Asthma, Allergic Rhinitis Coronavirus Disease 2019 and Asthma, Allergic Rhinitis
A new review provides insight into the molecular mechanisms and environmental factors involved in the immune response to SARS-CoV-2 infection among asthma and allergy patients.Current Opinion in Allergy and Clinical Immunology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 13, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology Journal Article Source Type: news

JB Chemicals gets USFDA nod for generic product
The US Food and Drug Administration (USFDA) has approved company's abbreviated new drug application (ANDA) for Loratadine tablets USP 10 mg for treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy, JB Chemicals and Pharmaceuticals said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 8, 2021 Category: Pharmaceuticals Source Type: news

Pollen levels might trigger flares of urologic chronic pelvic pain
(Wolters Kluwer Health) As anyone living with hay fever can attest, days with high pollen counts can bring attacks of sneezing, nasal congestion and other allergy symptoms. Now, a new study suggests rising pollen levels may also trigger flare-ups of pain and other symptoms in patients with urologic chronic pelvic pain syndrome (UCPPS), reports The Journal of Urology ® , Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 5, 2021 Category: International Medicine & Public Health Source Type: news

Janssen Headlines American Society of Hematology Annual Meeting With More Than 35 Presentations Highlighting Deep, Diverse Oncology Pipeline and Portfolio
RARITAN, N.J., November 5, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today more than 35 company-sponsored studies, including 10 oral presentations, will be featured at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition taking place virtually December 5-8, 2020.In multiple myeloma, highlights include Phase 1b/2 results for the B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor T-cell (CAR-T) therapy ciltacabtagene autoleucel (cilta-cel); new and updated data for the anti-CD38 monoclonal antibody DARZALEX® (daratumumab) and the subcutaneous for...
Source: Johnson and Johnson - November 5, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news